Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004961982 | SCV005469515 | uncertain significance | Inborn genetic diseases | 2024-12-06 | criteria provided, single submitter | clinical testing | The c.3405C>G (p.D1135E) alteration is located in exon 15 (coding exon 15) of the PKD1 gene. This alteration results from a C to G substitution at nucleotide position 3405, causing the aspartic acid (D) at amino acid position 1135 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005017305 | SCV005640923 | uncertain significance | Polycystic kidney disease, adult type | 2024-05-03 | criteria provided, single submitter | clinical testing |